Sunil Agarwal
CIK: 0001616640
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
28.2K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
Disposition(D)DirectStock Option (Right to Buy)
26.6K shares- - Jun 25, 2025ARVN
ARVINAS, INC.
Award(A)Direct16K shares- - Jun 11, 2025ATXS
Astria Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
26.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 23, 2026 |  ATXS Astria Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 28,200 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition(D) Stock Option (Right to Buy) | 26,550 | - | - | Direct |
| Jun 25, 2025 |  ARVN ARVINAS, INC. | Award(A) | 16,025 | - | - | Direct |
| Jun 11, 2025 | ATXS Astria Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 26,550 | - | - | Direct |
1-4 of 4 transactions
About AGARWAL SUNIL
AGARWAL SUNIL (SEC CIK 0001616640) files insider reports with the SEC as Director of Astria Therapeutics, Inc. (ATXS) and Director of ARVINAS, INC. (ARVN).
Signal8 holds 3 ownership filings by AGARWAL SUNIL, all Form 4s, filed between Jun 12, 2025 and Jan 23, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jan 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on AGARWAL SUNIL's filings is in BOSTON, MA.
Recent filings by AGARWAL SUNIL
Other insiders filing for Astria Therapeutics, Inc. (ATXS)
- Violin Jonathan, Director
- Morabito Christopher, Chief Medical Officer
- Milne Jill C., CEO and President
- Matthews Andrea, Chief Business Officer
- LAPOINTE ANTHONY GREGG, Director
- Komjathy Andrew, Chief Commercial Officer